XCUR
EXICURE, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.03
−8.04%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$19
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$19
- Revenue actual
- —
- Revenue estimate
- $1.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.9%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$19 | -$0.18 | Beat 99.03% | — |
| May 29, 2026 | -$19 | -$0.29 | Beat 98.44% | — |
| Mar 25, 2026 | -$19 | -$0.46 | Beat 97.53% | — |
| Nov 7, 2025 | — | -$0.39 | — | — |
| Aug 8, 2025 | — | -$0.41 | — | — |
| Jun 27, 2025 | — | -$0.45 | — | — |
| Mar 18, 2025 | — | -$3.39 | — | — |
| Nov 14, 2024 | — | -$0.57 | — | — |
| Aug 13, 2024 | — | -$0.35 | — | — |
| Jun 17, 2024 | — | -$0.50 | — | $500.0K |
| Nov 14, 2022 | -$4.50 | -$5.20 | Miss -15.56% | $2.0M |
| Aug 15, 2022 | -$1.20 | -$8.30 | Miss -591.67% | $2.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026